We demonstrated that PD98039, which serves as an ERK inhibitor, successfully up-regulated the level of E-cadherin, and down-regulated the level of MMP7 in vitro, leading directly to decreased migration and invasion in tumor cells. The gene discussed is MMP7; the disease is neoplasm.